Data as of Apr 17
| +0.23 / +7.67%|
The 2 analysts offering 12-month price forecasts for CytRx Corp have a median target of 11.00, with a high estimate of 12.00 and a low estimate of 10.00. The median estimate represents a +240.56% increase from the last price of 3.23.
The current consensus among 2 polled investment analysts is to Buy stock in CytRx Corp. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.